Detail Product Description

FLEXISEQ is a topically applied gel. FLEXISEQ is specially formulated to combat joint pain associated with osteoarthritis. Daily application in the morning and evening is enough to start to bring about real improvement in joint pain in as little as two days. FlexiSEQ Max Strength does not contain any pharmaceutical drug and consequently FLEXISEQ benefits from an excellent safety profile avoiding theociated with many common pain medicines. FLEXISEQ is clinically proven to greatly reduce pain and restore joint function (mobility). FLEXISEQ was shown to be as effective as a leading oral prescription-only medicine in trials with over a thousand patients, without the usual contraindications and adverse effects those may have.

Ingredients:

Aqua, Phosphatidylcholine, Alcohol, Glycerin, Carbomer, Polysorbate 80, Disodium Phosphate, Sodium Hydroxide, Benzyl Alcohol, Methylparaben, Ethylparaben, Linalool, Disodium EDTA, Sodium Phosphate, Sodium Metabisulphite, BHT.

Directions:

• Flexiseq is for external use only. Apply twice daily, in the morning and the evening, to the soft tissues around the affected joint. Apply a quantity appropriate to the size of the joint being treated for example, for the knee joint 2.2g of gel is recommended (corresponding to a gel length of 7cm). Allow the treated area to dry out before covering. Consult instructions for use.

Safety Warnings:

• Do not use FlexiSEQ:
• If you are allergic (hypersensitive) to any of the ingredients in FlexiSEQ.
• On open wounds, broken or infected skin or mucous membranes (the lining of the openings of the body, such as the mouth, nose, or eyes).
• If Pregnant or breastfeeding. FlexiSEQ has not been tested on pregnant women in clinical trials and therefore its use during pregnancy is not advised unless it has been deemed necessary by your doctor.
• It is unknown whether FlexiSEQ may be harmful to your child if you are breastfeeding. Please ask your doctor or pharmacist for advice before using the product.
• FlexiSEQ has not yet been tested on children. Use in these patients should be discussed with your doctor.